Validation and characterization of DNA microarray gene expression data distribution and associated moments by Thomas, Reuben et al.
RESEARCH ARTICLE Open Access
Validation and characterization of DNA microarray
gene expression data distribution and associated
moments
Reuben Thomas
1, Luis de la Torre
2, Xiaoqing Chang
1, Sanjay Mehrotra
2*
Abstract
Background: The data from DNA microarrays are increasingly being used in order to understand effects of
different conditions, exposures or diseases on the modulation of the expression of various genes in a biological
system. This knowledge is then further used in order to generate molecular mechanistic hypotheses for an
organism when it is exposed to different conditions. Several different methods have been proposed to analyze
these data under different distributional assumptions on gene expression. However, the empirical validation of
these assumptions is lacking.
Results: Best fit hypotheses tests, moment-ratio diagrams and relationships between the different moments of the
distribution of the gene expression was used to characterize the observed distributions. The data are obtained
from the publicly available gene expression database, Gene Expression Omnibus (GEO) to characterize the
empirical distributions of gene expressions obtained under varying experimental situations each of which providing
relatively large number of samples for hypothesis testing. All data were obtained from either of two microarray
platforms - the commercial Affymetrix mouse 430.2 platform and a non-commercial Rosetta/Merck one. The data
from each platform were preprocessed in the same manner.
Conclusions: The null hypotheses for goodness of fit for all considered univariate theoretical probability
distributions (including the Normal distribution) are rejected for more than 50% of probe sets on the Affymetrix
microarray platform at a 95% confidence level, suggesting that under the tested conditions a priori assumption of
any of these distributions across all probe sets is not valid. The pattern of null hypotheses rejection was different
for the data from Rosetta/Merck platform with only around 20% of the probe sets failing the logistic distribution
goodness-of-fit test. We find that there are statistically significant (at 95% confidence level based on the F-test for
the fitted linear model) relationships between the mean and the logarithm of the coefficient of variation of the
distributions of the logarithm of gene expressions. An additional novel statistically significant quadratic relationship
between the skewness and kurtosis is identified. Data from both microarray platforms fail to identify with any one
of the chosen theoretical probability distributions from an analysis of the l-moment ratio diagram.
Background
The current biological literature makes extensive use of
gene mRNA expression data from experimental systems
called gene chips/gene micro-arrays. These data are
used to infer genomic level conclusions. For example, to
infer the response of an organism or cell culture under
treatment or perturbation. Microarrays as an
experimental system are very valuable in that they pro-
vide a genome-wide picture (for all the (~30000) genes).
Unfortunately, because of costs of collecting microarray
data, the number of samples per treatment is quite
small (~2-10).
The data from microarrays are noisy. There are a
number of reasons to expect variability in the measure-
ments of the expressions of the genes in mammalian
organisms. These include biological causes, or the noise
associated with the steps involved in the measurement
of the gene expression. Depending on the question that
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any medium, provided the original work is properly cited.the researcher is trying to answer, he/she would have to
control for many of these sources of variation of gene
expression. This paper is interested in understanding
the variation in the expression data after the known/
reported sources of variation have been controlled for.
The biological variability could be due to genetic or
non-genetic factors [1] studies the cis-acting variation
that explains differences of 15 genes in the human brain
[2] reviews literature to suggest that the allele-specific
differences in the rates of transcription are common.
Other studies demonstrating the influence of genotype
on gene expression include [3] (in the human thyroid
tissue), [4,5] (in human lymphoblastoid cell lines), [6]
(human blood leukocytes), [7] (in human liver tissue)
and [8] (in liver tissue from mice of different strains).
Among the non-genetic factors explaining the varia-
tion in gene expression include the gender of the organ-
ism - [9] (in human skeletal muscle), [10] (in human
white blood cells), [11] (in human peripheral blood
mononuclear cells), [12] (in human retina), [13] (in
human blood) and [14] (in the liver and kidney of mice
and rats). Age of the organism was shown to be a signif-
icant covariate in [12] (in human retina), [11] (in human
peripheral blood mononuclear cells), [9] (in human ske-
letal muscle) and [13] (in human blood). There is a sig-
nificant variability of gene expression across different
tissue or cell types [15,16]. There is even variation
within a given tissue due to the presence of multiple
cell types - [11,13] (in human blood), [9] (in human ske-
letal muscle) and [17] (in human placenta). Other
important factors include the diet and fasting status of
the organism [14] and the time of day that the samples
were taken [13]. Another important variability factor is
the environmental condition that the organism was
under before the tissue sample was taken - for example
the mice could be sleep deprived [18], undergoing cra-
niofacial development [19], given oral doses of synthetic
triglycerides [20] or fed doses of chemicals that are
known to be lung carcinogens [21] or it could be medi-
cal students under psychological stress before a major
exam [22].
The other classes of non-genetic gene expression
variability that has been studied intensively (theoretically
and experimentally) have been termed intrinsic, extrinsic
and pathway-specific or global noises (see [23,24] for
reviews on this). Intrinsic noise is assigned to variation
arising because of the stochastic nature of transcription
and translation due to the small number of mRNA and
protein molecules. Extrinsic noise could be due to
changes in the cellular environment. These noises can
be demonstrated experimentally by observing the output
of two different reporters for the same gene in the same
cell and separate cells. Pathway-specific noise can be
viewed as the noise that is transferred along all the
genes whose genes sequentially participate in given cel-
lular or biochemical process.
Variability could arise at various stages involved in
getting the output from a microarray and also after data
from the microarray are obtained. This is in terms of
intensity measurements (for the predefined surrogates
for different genes that are termed probe sets) being
normalized and preprocessed to get estimates of gene
expressions. RNA are isolated from the cells obtained
from the tissue sample has been drawn from the organ-
ism. The RNA are then subjected to the process of
reverse transcription (RT) to obtain cDNA that are then
subjected to the vitro transcription (IVT) process to
obtain cRNA using polymerases. The cRNA are then
hybridized to probes on the microarray platform [25].
The factor that influence the final intensity measure-
ments for different probes include the amount of poly-
merase used for the IVT process, the amount of time
allotted for this process by the experimenter and the
binding specificity of the cRNA to the corresponding
probe sequence on the microarray platform [26]. Tu et
al [25] performed a small controlled analysis of the
noise characteristics in the gene expression data from
microarrays. They provide empirical distributions of
gene expressions arising just because of the variation
introduced by the above described process of getting to
intensity values from the microarray, i.e., they performed
an analysis of the measurement variability. It does not
seem trivial to control for a consistent microarray
experiment protocol - [14] demonstrated that the
laboratory where the microarray experiment was per-
formed is a major source of variation [27] found that
microarray experiments performed in different years had
different characteristics of gene expression. Different
microarray data preprocessing and normalization algo-
rithms generate expression data with different character-
istics [28]. In addition, microarrays as tools for detecting
changes in gene expression have been shown to be sen-
sitive and specific in a well defined range of its output
or gene expression. Low gene expression can be con-
fused with optical noise while due to saturation, changes
at higher levels of gene expression are more difficult to
detect [29].
Most of the current journals require the microarray
data to be deposited on a database (like the Gene
Expression Omnibus, GEO [30]) if these data were used
for analysis in a paper. The data deposited on the data-
base are in the form of multiple samples corresponding
to each of multiple conditions (typically one of these
conditions would correspond to the normal situation
when there is no disease or toxin dosed). The data are
deposited depending on the type of microarray chip
used. There are different commercial manufactures of
microarrays - Affymetrix and Agilent being the most
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specific organisms (mouse, rat, frog, human zebrafish
etc.) and within chips for specific organisms also there
are different varieties.
One of the main areas where microarray data has had
its application is in the identification of differentially
expressed genes across varying treatment conditions.
The approaches used could be classified based on
whether they use parametric assumptions about the
underlying distribution the gene expression or not. Kerr
et al [31] used a ANOVA model to capture variation of
gene expression arising from two color microarrays. The
non-normality of the residuals of this model was noted
in this work. Newton et al [32] assume that all gene
expressions are gamma distributed - a distribution that
is right skewed and whose coefficient of variation
decreases with increasing mean. They attempted to vali-
date this using real data and found that the fits did cap-
ture the primary features of variation but were poor in
general. Rocke and Durbin [33] assume a additive-multi-
plicative error model for gene expression that is additive
at low levels of gene expression and multiplicative at
higher levels of expression. So by this one would expect
the gene expression to be log-normally distributed at
high levels of gene expression. Then there are a class of
approaches called empirical Bayes methods - [34-36] are
examples - that make prior assumptions about the dis-
tribution of gene expression and then use the data itself
to get the posterior probability of the gene being differ-
entially expressed. They are all based on the observation
that mean and the coefficient of variation of the distri-
bution of gene expression have a definite pattern of var-
iation (eg. see [37]). The typical microarray set up uses
a relatively small number of samples to generate data
for tens of thousands of genes. The empirical Bayes
approaches essentially attempt to improve the estima-
t i o no ft h ev a r i a n c eo fag i v e ng e n eb yu t i l i z i n gt h e
observed pattern of variation between mean and the
coefficient of variation of expression of all the target
genes in the system [34,35] assume normal priors of
gene expression [36] assumes a normal prior for the dif-
f e r e n c ei nm e a n so ft h eg e n ee x p r e s s i o no v e rt h et w o
conditions. Non-parametric methods have also been
proposed to be used for the analysis of differential
expression (eg. see [38]). Popular permutation-based
method based on a modified t statistic is the so called
SAM statistic and its modifications [39,40]. Bayesian
network inference represents another analysis that
makes use of gene expression data and typically assumes
that the data is normally distributed - [41] and [42]. An
additional analysis where gene expression has been sig-
nificantly used is in the development of a prediction
model or a classifier - for example in the development
of a classifier between two different forms of leukemia
[43], prediction of prognosis of patients with breast can-
cer [44] and the prediction of potential carcinogenicity
of a chemical [45]. Such analyses do not make distribu-
tional assumptions on the expression of the gene
expression data and the efficacy of the models developed
in the above examples was done using cross-validation
of data.
The above paragraph describes a snapshot of the ana-
lysis done using gene expression data, some of the ana-
lyses make use of distributional assumptions and some
do not. Since distributional assumptions are made fre-
quently, it appears prudent to validate this assumption.
As mentioned above Newton et al [32] and Kerr et al
[31] attempted to verify their distributional assumptions
and did not find their assumptions adequately supported
by the data. Tu et al [25] did not consider the analysis
of variation due to biological variability. The literature
thus lacks an empirical validation of the distribution of
gene expression as measured by microarrays across mul-
tiple univariate theoretical distributions with sufficient
amount of data.
Since 2002 a significant amount of data from sources
l i k et h eG e n eE x p r e s s i o nO m n i b u sG E O[ 3 0 ]a n d
ArrayExpress ([46] has become available. This data can
now potentially be used to validate the distribution and
noise assumptions for statistical analysis and to develop
improved inference methods to analyze the microarray
data.
This paper focuses on identifying and validating
empirical distribution fits o fg e n o m e - w i d eg e n ee x p r e s -
sions as measured by microarrays. In addition to the
normal distribution we empirically tested the empirical
fit for a number of well established probability
distributions.
We analyzed four microarray data sets from the GEO
database [30]. They were all generated using the Affy-
metrix Mouse 430.2 platform. They are data from three
tissues - brain, liver and craniofacial tissue and expres-
sion data for the so called “house keeping” genes [47]
across over 6000 samples collected over a wide range of
conditions. These data sets were chosen in part because
they each had a relatively large number of samples gen-
erated by the same laboratory. Also, in light of the
points mentioned the samples in two of the datasets
(from the craniofacial and liver) were partially matched
for gender, age, mouse strain tissue source and environ-
mental conditions prior to sample collection. The data
set from the brain involved three different strains of
mice. The microarray data were preprocessed and nor-
malized in the same manner. It is therefore expected
that the primary sources of variability in gene expression
would be a convolution of intrinsic, extrinsic, pathway-
specific or global noise and noise associated with micro-
array sample preparation and hybridization to the DNA
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of mice for all the samples. The brain data set would be
expected to show additional genetic variation due to the
utilization of three different strains in the generation of
the samples.
Methods
Data sets used in the analysis
The microarray samples used in the analyses in this
manuscript were based in part on six separate data sets
(see Table 1 and Additional files 1, 2, 3, 4, Table S8,
Table S3, Table S1 and Table S2 for better detail of the
data in Table 1) obtained from the GEO database [30].
Four of them were from the Affymetrix Mouse Genome
430.2 array that uses a single color, in situ oligonucleo-
tide array technology while the other two were from a
non-commercial platform using a two-color, spotted oli-
gonucleotide array technology.
The GEO series codes for three of the Affymetrix data
are GSE7759, GSE8396 and GSE9444-termed respec-
tively as “Craniofacial”, “Liver” and “Brain” based on the
tissues from which the samples were drawn. The specific
samples identified by their GSM codes that were used
from the three data sets are provided in Additional file
3 ,T a b l eS 1 .T h e r ew e r e1 0 5s a m p l e sp r e s e n ti nt h e
“Craniofacial” data set, 93 samples in the “Liver” data
set and 69 samples in the “Brain” data set.
The data in the “Craniofacial” data set was analyzed in
[19] where craniofacial development in mice was stu-
died. C57BL/6J mice were sampled at 12 hour intervals
from E10.5-E12.5. It is during this time that the facial
structures in the mice form. Tissues from three distinct
regions - frontonasal, maxillary and the mandibular pro-
minence at each of these time points and analyzed for
transcriptomic changes. Seven biological replicate sam-
ples were collected from each of these regions at every
12 hour time interval.
T h ed a t ai nt h e“Liver” data set was analyzed in [20]
where the effects of various synthetic dietary triglycer-
ides on the hepatic gene expression were studied. One
of the objectives of this study was to understand the
role of PPARa in the observed effects. Male mice of
SV129 strain and PPARa-/- mice (2-6 months of age)
on SV129 background were used. Apart from a control,
the mice were treated with two synthetic agonists and
four synthetic triglycerides. There were four or five bio-
logical replicate samples for each treatment and wild
type or knockout mice combination.
T h ed a t ai nt h e“Brain” data set was analyzed in [18].
The objective of this study was to analyze the transcrip-
tomic changes in the brain and the liver resulting from
varying amounts of sleep loss in 3 different strains
(AKR/J, DBA/2J and C57BL/6J) of mice. In this manu-
script only a subset of the samples from the brain were
used. The mice of each strain were deprived of sleep for
various time periods. There were three biological repli-
cate samples per combination of strain and time period
of sleep deprivation.
In addition, 6219 microarray samples on the Affyme-
trix 430.2 platform were also downloaded from GEO
[30]. The GSM sample ids along with a description of
the experimental conditions under which the samples
were collected are given in Additional file 4, Table S2.
The samples were chosen using the GPLBrowse pro-
gram [48] in April 2009. This program plots various
moments of different samples on the GEO database ver-
sus each other. The scatter plot of the logarithm of
mean of expression of all the samples versus the loga-
rithm of the standard deviation of the samples on the
GEO database from the Affymetrix Mouse 430.2 was
visually examined. Samples that did not seem like out-
liers were chosen to form the set of samples that formed
the basis of our analysis. Note that the raw data was
downloaded in all cases and then preprocessed in a
well-defined manner (see below). These samples were
collected from mice of different strains, development
s t a g e s ,t i s s u e s ,s e x ,a n dd i f f e r e n tl a b o r a t o r i e so v e rt h e
past few years. The distribution of expression of the 21
house keeping genes identified in [47] was analyzed
using this data.
Table 1 Description of the data sets used
Data set GEO accession Technology No. of
Samples
Tissue Data
Craniofacial GSE7759 in situ oligonucleotide 105 craniofacial Logarithm of transcript measure
Liver GSE8396 in situ oligonucleotide 93 liver Logarithm of transcript measure
Brain GSE9444 in situ oligonucleotide 69 brain Logarithm of transcript measure
Housekeeping Additional file 4, Table
S2
in situ oligonucleotide 6219 mixed Logarithm of transcript measure
Male GSE2814 spotted
oligonucleotide
155 liver Logarithm of transcript measure relative to common
pool
Female GSE2814 spotted
oligonucleotide
156 liver Logarithm of transcript measure relative to common
pool
Further detailed description of these data sets are provided in Additional files 1, 2, 3, 4: Table S8, Table S3, Table S1 and Table S2
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cleotide array (GEO accession: GSE2814) were analyzed
in a number of papers [49-54] where one of the goals
was to sex-specific and tissue-specific differences in
gene expression. The data were from the liver of ApoE
null (C57BL/6J × C3H/HeJ)F2 intercross mice. There
were 155 male samples and 156 female samples - the
data sets is hereafter called “Male” and “Female”
respectively.
Data preprocessing and normalization
For each of the four Affymetrix data sets used, raw
C E Lf o r m a td a t af r o mG E Ow a sn o r m a l i z e du s i n gt h e
R Bioconductor [55] implementation of the GCRMA
normalization procedure [56]. The Affymetrix Mouse
430.2 platform has data for 45101 probe sets in all.
Each of the probe sets potentially map to a gene in the
mouse genome. The samples in each of the “Craniofa-
cial”, “Liver” and “Brain” data sets were normalized
separately. As described in the previous section, only a
small subset of samples in each of three datasets was
replicates, the remaining was obtained under different
conditions (e.g. different development stage in a differ-
ent facial region for the “Craniofacial” data). The
altered conditions would have effects on the expres-
sions of some of the genes in each of the data sets. In
this manuscript, for each of the three datasets ("Cra-
niofacial”, “Liver” and “Brain”) an attempt is made to
identify those probe sets or genes whose expressions
were not altered under all the conditions involved.
This is done using the non-parametric Kruskal-Wallis
one way analysis of variance test [57] for the expres-
sions of each gene across all samples in a given data
set. Probe sets with a p-value greater than a liberal 0.1
cutoff from the Kruskal Wallis test were deemed to be
unaffected by any of the conditions involved in the
generation of a given data set. Results of varying this
0.1 cutoff sensitivity to the results of distributional
tests are provided in the Additional material. The
Kruskal-Wallis test also assumes that the distributional
form of the data being compared across the conditions
remains the same. An alternate method that does not
need the above assumption is the analysis using boot-
strapping of residuals [58] from a heteroscedastic one-
way anova model [59]. However, this assumption
results in over 99% of all probe sets (data not shown)
in each of the three data sets being deemed unchanged
over conditions involved in generation of the probe
sets.
For the data set of 6219 microarray samples RAM
memory limitations prohibit normalizing all samples
together. To normalize these, the following steps were
followed:
1. The samples were partitioned into sets of 75.
2. The gene expression data for each of these 75
samples were obtained after running the GCRMA
routine.
3. Using the data from step 2, the gene expression
across the whole data set of 6219 samples were nor-
malized with respect to each other using the quantile
normalization method as described in(Bolstad B:
Probe level quantile normalization of high density
oligonucleotide array data. Unpublished manuscript
2001.).
Yang et al [54] that use the “Male” and “Female” data
define “active expressed” g e n e sa n dap r o c e d u r et o
obtain them. In summary, genes differential expressed
with respect to the reference pool are identified by a
p-value cutoff of 0.01 from an error model used in their
analysis. In addition to this set of transcriptionally active
genes, genes that were significantly correlated (Pearson
correlation p-value < 10
-5) with these active genes were
also chosen. This combined set of genes is what is used
in the analysis in this paper. In the interest of having a
relatively large number of genes for analysis, further cri-
t e r i au s e db yY a n ge ta l[ 5 4 ]l i k ep r e s e n c eo fa ne Q T L
with LOD score cutoff or significant correlations with
the characterized traits of adiposity, plasma lipids, or
atherosclerosis were ignored. The log ratio data were
used then used as-is as downloaded from GEO.
Testing Distributional Assumptions
For each of the data sets “Craniofacial”, “Liver” and
“Brain”, “Housekeeping”, “Male” and “Female”,K o l m o -
gorov-Smirnov (KS) and Anderson-Darling (AD)
hypothesis tests were used to test distributional assump-
tions. Both test the null hypothesis that a set of data
comes from a given distribution, with distributional
parameters possibly unknown. The AD test is more sen-
sitive to differences in the tails of the data than the KS
distribution. In testing for Normality, the AD test is
known to be more powerful than the KS test [60]. Nor-
mal, log-normal, logistic, log-logistic, Weibull, and
extreme value distributions were tested. The “Male” and
“Female” data were just tested on the normal, logistic
and extreme value distributions because the log-ratio
data from these data sets could be negative. The distri-
butions were chosen because both tables of critical
values for the tests with unknown distribution para-
meters and efficient implementations of parameter are
available. In this manuscript the results for the AD are
provided while those for the KS tests are provided in
the Additional material.
For each of the data sets and each distribution F, each
of identified (either by the Kruskal Wallis test for the
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actively expressed for the “Male” and “Female” data sets,
as explained in the previous section) probe sets were
tested in the following manner:
1. Use maximum likelihood estimation (MLE) to
estimate 
∧
for F
2. Use the KS and AD tests at the 90% and 95% to
test whether the probe data comes from F() 
∧
.
For each of these distributions, MATLAB version
R2009B Statistics Toolbox MLE functions were used.
Critical values can be found in [60].
In addition, for housekeeping genes, KS and AD tests
were used to test for gamma and Pareto distributions
across a set of 6219 samples. For these distributions,
tables of critical values do not exist, but a method for
generating p-values for KS tests with unknown distribu-
tion parameters from [61] was used. For the gamma dis-
tribution, MATLAB code Fastfit [62] was used for
parameter estimation. For the Pareto distribution,
known closed-form solutions for ML estimators are
used.
L-moment ratio diagram
The l-moment ratio diagram [63,64] of l-skewness verus
l-kurtosis was created using the “lmomc” package [65]
in the R statistical software [66].
Mixture distribution fit
The “Male” and “Female” data were fitted to mixture of
normal distributions using the “mixdist” package [67] in
the R statistical package [66].
Results
The Kruskal Wallis test was used on the logarithm of
expression of the probe sets in each of the “Craniofa-
cial”, “Liver” and “Brain” data sets in order to identify
those that were most likely unaffected by any of the
conditions involved in the generation of these data sets.
T h er e s u l t si nT a b l e2i n d i c a t et h a tm o r et h a n5 0 %
(~25000/45000) of the probe sets were unaffected in the
“Brain” data set while a far fewer were unaffected for
the “Craniofacial” and the “Liver” data sets. Further the
results in Table 2 indicate that of these unaffected
probe sets for each of the three data sets, more than
50% rejected the null hypotheses (at a 95% confidence
level) for all the distribution tests considered - Normal,
Weibull, Extreme value, Logistic, Log-normal and Log-
logistic. The same can be said about the house keeping
genes [47]. The data for these are based on 6219 micro-
array samples. Also, it seems that at least one of the
above six distributions failed to be rejected for between
25 and 52% of the probe sets in each of the three data
sets. Additional simulation-based Anderson-Darling
(AD) tests were performed for the Gamma and Pareto
distributions for the house keeping genes. 23/23 house-
keeping probe sets rejected the AD null hypothesis for
the Gamma distribution at the 95% confidence level
while only 2/23 rejected the hypotheses for the Pareto
distribution. However, the Kolmogorov-Smirnov (KS)
test rejected 23/23 null hypotheses for both the Gamma
and Pareto distributions. Additional results obtained by
varying the Kruskal Wallis test p-value cutoff and the
results obtained from the Kolmogorov-Smirnov good-
ness of fits tests are given in Additional files 5 and 6,
Tables S6 and S4 respectively. Detailed probe level
results are provided in Additional file 7, Table S5.
The results of the goodness of fit Anderson-Darling
distribution tests for the “Male” and “Female” data sets
showed different characteristics from those of the other
data sets. Only around 43-46% of the probe sets rejected
the normal hypothesis (as compared with 72-82% for
the previous data sets). The logistic distribution was
rejected less often than the previous data sets (21-24%
as compared with 69-79%). The fit of the extreme value
distributions were equally bad for both sets of data. This
difference in characteristics of the goodness of fit test
results between two different microarray platforms indi-
cates the contribution of technology and/or of the nor-
malization methodologyt ot h ed i s t r i b u t i o n
characteristics of microarray data.
The dependence of the mean on the higher order pro-
duct moments are shown in Figures 1 and 2 - 1(a)-1(c),
2(a)-2(b): (mean versus coefficient of variation), 1(d)-1
(f), 2(c)-2(d): (mean versus skewness) and 1(g)-1(i), 2(e)-
2(f): (mean versus kurtosis). Note in the case of the
“Male” and “Female” data sets the higher order
moments are plotted against the absolute value of the
mean of the log-ratio data. The overall trends of the
higher moments with the means are consistent. Note
that in the range of lower mean expression the coeffi-
cient of variation, skewness and kurtosis are unusually
high. This probably reflects genes whose expressions are
below the detection limit of the microarray and can be
treated as optical noise [29] for the case of the Affyme-
trix data. For the “Male” and “Female” data this may
r e f l e c tt h ei n s t a b i l i t yo ft h er a t i of o rl o we x p r e s s i o n
genes. By visual inspection of Figure 1, a value of 6 is
chosen as cutoff of mean of the logarithm of gene
expression so that mean of the logarithm of the mea-
surements of the gene expression below 6 are consid-
ered noise and a cutoff of 0.05 absolute value of ratio
w a sc h o s e nf o rF i g u r e2 .L o e s sc u r v e s( r e p r e s e n t e db y
green lines in the subplots) are fit through the noisy
measurements and polynomials (represented by red
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describe the trend between mean and the next three
higher product moments. A linear fit to the trend
between the logarithms of the coefficient of variation
(CV) and the mean of the logarithms of mean of expres-
sion of different genes are shown in Figure 1. The para-
meters of the linear fit are given in Table 3. The
decreasing trend of the coefficient of variation with the
mean of gene expression is valid across the five data
sets. This recapitulates what is already known about
microarray data (see [35]). The suggestion of consistency
between the trends is also clear from observation of the
coefficients in Table 3 (separately for the Affymetrix
data sets and the Rosetta/Merck ("Male”, “Female”)d a t a
sets). This consistency is however not statistically valid.
Also, note that the confidence intervals generated for
the parameters in Table 3 are probably not entirely valid
given issues of heteroscedasticity and non-normality of
the residuals associated with the three fits (see Addi-
tional files 8, 9, 10, Figures S1-S3). Skewness and kurto-
sis did not have a significant trend with the mean of
distribution the gene expression as measured by the R
2
Table 2 Fraction of null hypotheses rejected by the Anderson-Darling tests for best fit to 7 distribution functions
Dataset Probe set
no.
Normal Weibull Extreme
Value
Logistic Lognormal Log-
logistic
At least one of the distributions not
rejected
Craniofacial 6215 0.72 0.79 0.82 0.69 0.75 0.71 0.46
Liver 6228 0.82 0.93 0.95 0.79 0.83 0.8 0.25
Brain 25146 0.77 0.92 0.93 0.69 0.77 0.68 0.35
Housekeeping 23 0.7 1 1 1 0.48 1 0.52
Male 19532 0.46 NA 0.96 0.24 NA NA 0.82
Female 18915 0.43 NA 0.96 0.21 NA NA 0.85
The fraction is the number of probe sets that reject a given hypothesis out of the number of the probe sets (that is given in the second column). The number of
probe sets in the second column were the ones that were assumed to be unaffected by the conditions involved in the generation of all samples in each of the
six data sets - “Craniofacial”, “Liver”, “Brain”, “Housekeeping”, “Male” and “Female”. Probe sets were deemed to be unaffected for the first three data sets using
the Kruskal Wallis test as described in the Methods section. The “Housekeeping” data set had 6219 samples and the 23 probe sets analyzed corresponding to the
so-called housekeeping genes [47] that are supposed to be essential for cell-survival under most conditions. The probesets for the “Male” and “Female” data sets
were identified using the procedure detailed in the Methods section. Note some of the log ratio data for the “Male” and “Female” data sets are negative and so
cannot be tested for goodness-of-fit to some of the distributions. The results for these distributions are listed as “NA”.
Figure 1 Scatter of mean versus coefficient of variation, skewness and kurtosis of distribution of gene expressions for the three
Affymetrix data sets. The green curves in each of the plots represent the loess curves for scatter of each of the three higher moments
(coefficient of variation, skewness and kurtosis) versus the mean of the gene expression for all those genes whose mean is less than 6. The red
curves represent the best fit polynomials for scatter of the higher moments versus the mean for all those genes or probe sets whose gene
expression is greater than 6. The fitted trend is linear between the logarithm of the coefficient of variation and the mean of the distribution of
the log of gene expressions and constant for the relationships between skewness and mean and between kurtosis and mean.
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Page 7 of 14values for different polynomial fits (the R
2 values did not
exceed 0.1). So the mean values of skewness and kurto-
sis are plotted by the red lines in Figure 1d-1i, 2c-2f.
T h e s em e a nv a l u e sa r eg i v e ni nT a b l e4 .T h eN o r m a l
distribution has a skewness value of 0 and a kurtosis of
3. The values in Table 4 suggest a majority of the distri-
butions of gene expression as being more negatively
(positively) skewed than the Normal and as having a
higher (higher) kurtosis value for the Affymetrix
(Rosetta/Merck) data.
The relationship between the kurtosis and the skewness
of the distribution of gene expressions is studied next.
The variations of kurtosis of the distribution of gene
expression with skewness for the three data sets are
plotted in Figures 3 and 4. Note this plot is restricted to
only those genes with mean expression greater than 6
for Figure 3 and absolute value log ratio greater than
0.05 for Figure 4. The quadratic fits to the trends are
also shown in Figures 3 and 4. The coefficients of the fit
are given in Table 5. The confidence intervals for these
coefficients may again be questioned given the issues
with the heteroscedasticity and non-normality of the
residuals (see Additional files 11, 12, 13, Figures S4-S6).
Alternate non-linear models were evaluated for their
Figure 2 Scatter of mean log ratio versus coefficient of variation, skewness and kurtosis of distribution of gene expressions for the
two Rosetta/Merck data sets. The green curves in each of the plots represent the loess curves for scatter of each of the three higher
moments (coefficient of variation, skewness and kurtosis) versus the mean log ratio of the gene expression for all those genes whose absolute
value is less than 0.05. The red curves represent the best fit polynomials for scatter of the higher moments versus the mean for all those genes
or probe sets whose absolute value of the mean log ratio of gene expression is greater than 0.05. The fitted trend is linear between the
logarithm of the coefficient of variation and the mean of the distribution of the log of gene expression ratio and constant for the relationships
between skewness and mean and between kurtosis and mean.
Table 3 Coefficients of the linear trends between the
logarithm of the coefficient of variation (CV) and the
mean of the distribution of the logarithm of gene
expression for each of the three data sets
Data set Intercept Slope R
2 p-value
Craniofacial -1.38 ± 0.06 -0.20 ± 0.01 0.6 0
Liver -1.99 ± 0.11 -0.19 ± 0.02 0.44 0
Brain -2.10 ± 0.04 -0.22 ± 0.01 0.62 0
Male 0.57 ± 0.02 -1.67 ± 0.12 0.29 0
Female 0.56 ± 0.02 -1.74 ± 0.13 0.3 0
Also included in the table are the 95% confidence intervals for these
coefficients, the coefficient of determination, R
2 and the p-value for the
goodness of fit F-test to the linear model. Note that the models are computed
using data over those probe sets with mean expression greater than 6 in
order to avoid analysis with noisy or low expression genes.
Table 4 Means of skewness and kurtosis of distribution
of log of gene expression
Data set Mean skewness Mean kurtosis
Craniofacial -0.39 ± 0.03 4.02 ± 0.12
Liver -0.16 ± 0.03 3.82 ± 0.08
Brain -0.1 ± 0.02 3.52 ± 0.03
Male 0.26 ± 0.05 5.20 ± 0.31
Female 0.40 ± 0.06 5.97 ± 0.38
Also included is the 95% confidence interval for these means. Note that the
means are computed over those probe sets with mean expression greater
than 6 in order to avoid analysis with noisy or low expression genes.
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Page 8 of 14ability to alleviate these issues. However a solution
wasn’t found that would make reduce both concerns
simultaneously. So in the interest of simplicity and also
given the fact the stated confidence intervals are not
used to draw further conclusions, the results are pre-
sented without making any further attempts to satisfy
the assumptions of homoscedasticity and normality of
residuals. Theoretically, the kurtosis (denoted by K)a n d
the skewness (denoted by S) have to satisfy the following
inequality (see [68]),
KS ≥+
2 1
The data in Table 5 are again suggestive (though not
statistically valid) of a consistent quadratic trend across
Figure 3 Scatter of kurtosis versus skewness and of distribution of gene expressions for the three data sets - “Craniofacial” in (a)
“Liver” in (b) and “Brain” in (c). The green circles represent the fit using the best fit quadratic polynomial. The blue line represents the
theoretical limit of the scatter between the skewness and the kurtosis of a probability distribution.
Figure 4 Scatter of kurtosis versus skewness and of distribution of gene expressions for the two data sets - “Male” in (a) and
“Female” in (b). The green circles represent the fit using the best fit quadratic polynomial. The blue line represents the theoretical limit of the
scatter between the skewness and the kurtosis of a probability distribution.
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Page 9 of 14the three data sets between kurtosis and skewness of the
distributions of gene expression.
Further validation of the lack of fit of gene expression
to any of the standard theoretical univariate probability
distributions can be seen in the L-moment ratio diagram
in Figure 5. The theory of L-moments was introduced in
[63] and they have been shown to provide unbiased esti-
mates of the higher order moments of a probability dis-
tribution. The standard product-moments have been
shown to be significantly affected by the sample size
and the presence of outliers [64]. The relationship
between the third-order and fourth-order L-moments
(representing the skewness and kurtosis of the distribu-
tion) can be plotted on an diagram called the L-moment
r a t i od i a g r a m .T h i si ss h o w ni nF i g u r e5 .T h eL - s k e w -
ness and L-kurtosis for all the unaffected probe sets
(with mean expression greater than 6) in each of four
Affymetrix data sets are plotted in Figure 6a-6d and for
the actively expressed genes (with absolute value of log
ratio greater than 0.05) for the Rosetta/Merck data sets
in Figure 7a-7b. The l-moment plots with all the data
including those with mean expression less than 6 for the
Affymetrix data is provided in Additional file 14, Figure
S7 and those for all Rosetta/Merck data including those
with absolute value of mean of log ratio of gene expres-
sion greater than 0.05 is provided in Additional file 15,
Figure S8. The probe sets in each of these subplots
represented as circles are also colored. The intensity of
redness of probe set circle reflects its mean expression.
This coloring scheme points to the lack of dependence
of the L-(skewness and kurtosis) moments on the mean
expression. The consistent non-linear relationships
across the three data sets between the product moments
skewness and kurtosis identified in Figures 3 and 4 also
appear to hold for the l-skewness and l-kurtosis.
The samples from the “Male” and “Female” datasets
could be considered more or less homogenous with
respect to sex, tissue, diet and experimental conditions.
One reason we could be seeing poor fits to standard dis-
tributions could be that there are different modes to the
distribution of the expression of a given gene reflecting
the genetic variation in the F2 cross animals or a sto-
chastic network influence (e.g. gene involved in a given
biochemical pathway) of its expression [24]. Hence it is
possible for a mixture of distributions to better fit the
observed data. The results of chi-square fits to a three
normal mixture distribution are given in Table 6. There
is no improvement in fit to the mixture distribution on
comparison of the results with the chi-square fit to a
single normal.
Discussion
In the past several years, there has been an explosion in
amount of quantitative biological data either in terms of
transcriptomics, sequencing data, genetic structure var-
iation, proteomics or metabolomics. DNA microarrays
have been important and valuable resource for under-
standing perturbations to biological systems in terms of
identifying affected gene expressions. The standard sta-
tistical methods are being either directly used or modi-
fied to work with gene expression data. Unfortunately,
only a small number of replicate samples per treatment
(2-10) are used for analysis owing to the cost of the
experimentsal system. This point plus the fact that the
probability distributions of gene expressions as mea-
sured by these arrays were not characterized leads one
of logically question the use various statistical methods
that are based on distributional assumptions. Heuristics
Table 5 Coefficients of the quadratic trends between the
kurtosis and skewness of the distribution of the
logarithm of gene expression for each of the three data
sets
Data set Constant Linear Quadratic R
2 p-value
Craniofacial 2.96 ± 0.04 -0.31 ± 0.07 1.40 ± 0.03 0.91 0
Liver 3.30 ± 0.07 0.12 ± 0.10 1.42 ± 0.06 0.58 0
Brain 2.97 ± 0.03 0.03 ± 0.03 1.31 ± 0.03 0.65 0
Male 3.65 ± 0.34 -0.05 ± 0.27 1.21 ± 0.07 0.82 0
Female 3.85 ± 0.27 -0.12 ± 0.20 1.23 ± 0.05 0.89 0
Also included in the table are the 95% confidence intervals for these
coefficients, the coefficient of determination, R
2 and the p-value for the
goodness of fit F-test to the linear model. Note that the models are computed
using data over those probe sets with mean expression greater than 6 in
order to avoid analysis with noisy or low expression genes.
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Figure 5 Legend for the theoretical probability distributions in
the l-moment ratio diagrams provided as subplots in Figure 2.
GEV - Generalized Extreme Value, GLO - Generalized Logistic, GNO -
Generalized Normal, GPA - Generalized Pareto, PE3 - Pearson Type
III, EXP - Exponential, NOR - Normal, GUM - Gumbel, RAY - Rayleigh
and UNI - Uniform.
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Page 10 of 14Figure 6 Scatter of l-skewness versus l-kurtosis of gene expressions for the four data sets - “Craniofacial”, “Liver”, “Brain” and
“Housekeeping”. The scatter is overlaid on the relationships between these moments for standard theoretical distributions. The legend for
these distributions is provided in Figure 5. The l-skewness and l-kurtosis for the unaffected probe sets with mean expression greater than 6 for
the “Craniofacial”, “Liver”, “Brain” and “Housekeeping” datasets are plotted in the subplots (a), (b), (c) and (d) respectively. The intensity of red of
each circle that represents a probe set in these subplots is made to vary linearly with the mean expression of this probe set. So higher the
mean expression, the greater is the intensity of red.
Figure 7 Scatter of l-skewness versus l-kurtosis of gene expressions for the two Rosetta/Merck data sets - “Male” and “Female”.T h e
scatter is overlaid on the relationships between these moments for standard theoretical distributions. The legend for these distributions is
provided in Figure 5. The l-skewness and l-kurtosis for the unaffected probe sets with mean log ratio of expression greater than 0.05 for the
“Male” and “Female” datasets are plotted in the subplots (a) and (b) respectively. The intensity of red of each circle that represents a probe set in
these subplots is made to vary linearly with the mean expression of this probe set. So higher the mean expression, the greater is the intensity of
red.
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Page 11 of 14are being proposed that attempt to relax the reliance on
this distributional assumption. One example of this
would be the method of jointly using the p-value from a
two sample t-test along with the gene expression fold-
change to identify differentially expressed genes. Alter-
nately, there is an increased use of non-parametric
methods or permutation-based methods [69,38].
The essential question that we address in this manu-
script is whether the distribution of the logarithm of gene
expression as measured by DNA microarrays can be
approximated by any of the standard theoretical univari-
ate probability distributions. The results in Table 2 and
F i g u r e s6a n d7s u g g e s tt h a ti ti su n l i k e l yt h a tt h e r ei sa
known probability distribution that all gene expressions
would follow. Now if this is the case then an alternative
w o u l db ei st os e ei ft h e r ea r econsistent relationships
between the various moments of the distributions of the
gene expressions. The analyses in Figure 1, 2, 3, 4 suggest
that there are consistent (though not statistically valid)
relationships between the mean and coefficient of varia-
tion (Additional file 16, Table S7 lists the spearman rank
correlation between the mean and standard deviation of
the gene expressions corresponding to each of the data
sets analyzed) and the skewness and kurtosis of the dis-
tribution of gene expression respectively. Comparison of
results as obtained from a commercial Affymetrix plat-
form and a non-comercial Rosetta/Merck platform also
indicated the influences of the microarray technology on
the distribution characteristics of the data.
The observed distributional characteristics of gene
expression data in this manuscript suggest either the
need for the use of non-parametric statistical methods
or a need to develop newer statistical/mathematical
approaches that are capable of and are optimal for
working with these kinds of distributions.
Because of the nature of the data used in this paper,
w ea r eu n a b l et os e p a r a t et h ec o n t r i b u t i o nt ot h ev a r i a -
tion of the data due to biological reasons from those
induced by the microarray technology. The noise we
observe is probably the result of the convolution of
these two factors. In light of the increasing use of newer
technologies like those based on Next Generation
Sequencing [70] and despite the real possibility of the
reduced future use of DNA microarrays an analysis like
that presented in this paper would be useful in guiding
analyses of these new data and also in making distribu-
tional hypotheses.
Conclusions
The analyses of the empirical probability distribution of
gene expressions from five publicly available data sources
with relatively large number of samples have been
described in this manuscript. The failure of the distribu-
tions to follow any of the known theoretical univariate
probability distributions has been demonstrated though
the data suggests consistent relationships between the
different moments of the distributions. These moment
relationships should motivate the development of Baye-
sian methods with appropriately chosen priors.
Additional material
Additional file 1: Table S8: Detailed description of the data in Table 1.
This includes more description of the microarray platform and the base
pair length of the probes used on each of the microarray platforms.
Additional file 2: Table S3: List of housekeeping genes [47] analyzed.
Additional file 3: Table S1: GEO [30] microarray samples for the
“Craniofacial”, “Liver” and “Brain” data sets.
Additional file 4: Table S2: GEO [30] microarray samples used to
analyze the expression of probe sets corresponding to the house
keeping genes.
Additional file 5: Table S6: Results of goodness of fit tests for the
Anderson-Darling tests for the six analyzed probability distributions
obtained by the varying the cutoff for the Kruskal-Wallis test.
Additional file 6: Table S4: Best fit distribution Kolmogorov-Smirnov
test results for “Craniofacial”, “Liver”, “Brain”, “Male” and “Female” data
sets.
Additional file 7: Table S5: Probe set level best fit distribution results
for the Anderson Darling (AD) and the Kolmogorov-Smirnov test (KS)
tests at 90 and 95 percent confidence levels.
Additional file 8: Figure S1: Diagnostic plot for the linear model
between the logarithm of the coefficient of variation (CV) and the mean
of the distribution of the logarithm of gene expression for the
“Craniofacial” data set. Note the residual plots (subplots (b) and (c)) also
provide the pearson correlation (denoted by r) between the absolute
value of the residuals and the mean and logarithm of the CV
respectively.
Additional file 9: Figure S2: Diagnostic plot for the linear model
between the logarithm of the coefficient of variation (CV) and the mean
of the distribution of the logarithm of gene expression for the “Liver”
data set. Note the residual plots (subplots (b) and (c)) also provide the
pearson correlation (denoted by r) between the absolute value of the
residuals and the mean and logarithm of the CV respectively.
Additional file 10: Figure S3: Diagnostic plot for the linear model
between the logarithm of the coefficient of variation (CV) and the mean
of the distribution of the logarithm of gene expression for the “Brain”
data set. Note the residual plots (subplots (b) and (c)) also provide the
pearson correlation (denoted by r) between the absolute value of the
residuals and the mean and logarithm of the CV respectively.
Additional file 11: Figure S4: Diagnostic plot for the quadratic model
between the kurtosis and the skewness of the distribution of the
logarithm of gene expression for the “Craniofacial” data set. Note the
residual plots (subplots (b) and (c)) also provide the pearson correlation
(denoted by r) between the absolute value of the residuals and the
skewness and kurtosis respectively.
Additional file 12: Figure S5: Diagnostic plot for the quadratic model
between the kurtosis and the skewness of the distribution of the
Table 6 Fraction of null hypotheses rejected by the
Chi-square test for the goodness-of-fit to a normal
distribution and a mixture of three normal distributions
for the “Male” and “Female” data sets
Data set Normal 3-normal mixture
Male 0.18 0.17
Female 0.16 0.17
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Page 12 of 14logarithm of gene expression for the “Liver” data set. Note the residual
plots (subplots (b) and (c)) also provide the pearson correlation (denoted
by r) between the absolute value of the residuals and the skewness and
kurtosis respectively.
Additional file 13: Figure S6: Diagnostic plot for the quadratic model
between the kurtosis and the skewness of the distribution of the
logarithm of gene expression for the “Brain” data set. Note the residual
plots (subplots (b) and (c)) also provide the pearson correlation (denoted
by r) between the absolute value of the residuals and the skewness and
kurtosis respectively.
Additional file 14: Figure S7: l-moment ratio diagram for the four data
sets as in Figure 6 but including all probe sets including those with
mean expression less than 6.
Additional file 15: Figure S8: l-moment ratio diagram for the four data
sets as in Figure 7 but including all probe sets including those with
absolute value of mean of log expression ratio less than 0.05.
Additional file 16: Table S7: Spearman rank correlation between the
mean and standard deviation of the measured data for “Craniofacial”,
“Liver”, “Brain”, “Male” and “Female” data sets.
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